COVID-19 Prophylaxis South Africa (COVER HCW)

NCT04561063 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1950

Enrollment

OTHER

Sponsor class

Conditions

Covid19
SARS-CoV Infection

Interventions

DRUG: Nitazoxanide
DRUG: Sofosbuvir/Daclatasvir

Sponsor

University of Witwatersrand, South Africa